If you don't like it I suggest moving along. I expect EMD to continue its global collaboration as a leading expert in this field helping the rest of the world and other companies given that Australia's regulatory framework is leading and attractive. In contrast, the rest of the globe is still restrictive.
Market rate + R&D rebate + restricted market external to Australia = good business.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $16.50M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.8¢ | 2.7¢ | $51.56K | 1.876M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 199659 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 1040544 | 2 |
View Market Depth
| Last trade - 15.27pm 03/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |